Aims-To study the cutaneous and visceral distribution ofherpes simplex virus (HSV) and varicelia zoster virus (VZV) in fatal infections. Methods-Standard histology, immunohistochemistry (monoclonal antibodies VL8 and VL2 and polyclonal antibody IE63 directed against VZV; monoclonal antibodies IBD4 and HH2 and polyclonal antibodies directed against HSVI and HSVII) and in situ hybridisation (anti-HSV and anti-VZV probes) 
Infections by the varicella zoster virus (VZV) and herpes simplex virus (HSV) types I and II are potentially life-threatening, particularly in the immunocompromised host. Recent reports show a clear upward shift in the age of VZV infection and the associated mortality rate. 13 The clinical diagnosis of varicella, herpes zoster and herpes simplex infections may be difficult, especially when the cutaneous eruption is atypical as in immunocompromised patients." Extensive visceral dissemination can occur several days before the skin lesions appear. Typical histocytological diagnostic clues for HSV and VZV infections include the S Debrus, J Piette, B Rentier, G Lipcsei, presence of syncytial keratinocytes, Cowdry type A intranuclear inclusions, "ground-glass" nuclei, and/or limited haemorrhagic necrotic areas. However, the typical cytopathological changes are not always present and the VZV pneumonitis, which is the most frequent complication of varicella, may have non-specific histological aspects.9 Conversely, intranuclear inclusions are not always indicative of viral infection.
The mechanisms of organ dysfunction that may lead to a fatal outcome are not entirely known. Pathogenic hypotheses are based mainly on histological observations of rare necropsy reports. The direct effect of the viruses was only suspected by the presence of Cowdry type A intranuclear inclusions.
Currently, type specific identification of Herpesviridae infections on formalin fixed, paraffin wax embedded tissue is possible using polyclonal or monoclonal antibodies directed against envelope glycoproteins or nucleocapsid constituents ofHSV and VZV. 103 These results can be confirmed by in situ hybridisation with specific HSV and VZV nucleic acid probes. '415 During viral latency, HSV and VZV nucleic acids and some ct or immediate early (IE) gene transcripts, but not early (E) and late (L) proteins, are present in morphologically normal cells in the dorsal root ganglia.' '7 During productive VZV infection, some viral genome sequences and viral glycoproteins gE and gB have been detected in dermal cells without cytological alterations.'5 Further characterisation of viral expression in organs other than skin should highlight the distribution and the pathogenesis of disseminated infections by VZV and HSV.
This study, using histology, immunohistochemistry and in situ hybridisation, shows that the distribution ofVZV and HSV in various tissues and organs, collected at necropsy, of patients with visceral dissemination of HSV and VZV infection correlates with the major clinical signs. We also show that VZV and HSV can be detected in tissues lacking histopathological alterations during disseminated infections.
Case reports CASE 1
A 73 year old man presented with acute atypical abdominal pain. The past medical history included moderate idiopathic lymphopenia, partial prostatectomy for benign hyperplasia, type II diabetes, cholecystectomy, ancient myocardial infarction, corticosteroid dependent chronic obstructive lung disease (methyl-prednisolone, 4 mg/day for over 10 years), and partial gastrectomy after perforation of cardio-oesophagal peptic ulcers. A varicella-like eruption developed on his head and soon disseminated over his entire skin surface. The patient was febrile (39-40°C). Histological and immunohistological evaluations ofa skin biopsy specimen led to the diagnosis of varicella. Acyclovir therapy (7 5 mg/kg every eight hours) was initiated. Two days later, the patient experienced severe respiratory distress in association with disseminated intravascular coagulation, massive hepatolysis, and acute renal insufficiency. Anti-VZV IgM titres rose after four days, while IgG titres remained negative. The patient died from multisystem failure after six days. Necropsy was carried out four hours after death. CASE 2 A 40 year old woman presented with pain and zosteriform eruption present for three days in the L2-4 dermatomes. The relevant past medical history included centrocytic/centroblastic lymphoma, which had been treated three years before by corticosteroids The following controls for immunohistochemistry and in situ hybridisation were used. Biopsy specimens of clinically evident herpes zoster served as positive controls for VZV antibodies and nucleic acid probes. Biopsy specimens of herpes labialis and herpes genitalis were used, respectively, as controls for HSVI and II antibodies and HSV probes. Negative controls included normal skin obtained during surgery and at necropsy. Additional negative controls omitted the primary antibody or the DNA probe.
Results

GENERAL FINDINGS
Routine histology Table 2 summarises the results of routine histological examination. Some intranuclear inclusions, "ground-glass" nuclei, large eosinophilic nuclei, and giant cells were identified in the liver, lungs and skin of case 1, in the skin and lungs of case 2, and in the lungs and The diagnoses at necropsy in these thri were, respectively: case 1, disseminat aneous and visceral varicella with muli organ failure and fatal outcome; case dissemination of VZV after herpes zost tion; and case 3, primary extensive HSVI dissemination responsible fo tisystem organ failure and fatal outcon Table 3 shows the various organs anc in which VZV and HSVI were dete immunohistochemistry and in situ isation in areas where typical cytopath features of Herpesviridae infection were (figs 2 and 4). The other organs not me in tables 2 and 3 did not contain any e of viral infection on histology, immur chemistry or in situ hybridisation. In and 2, anti-HSV antibodies and HSV acid probes yielded negative results in sues. Anti-VZV antibodies and DNA were consistently negative in case 3. normnal skin and normal necropsy mater consistently negative. Discussion tX Fatal outcome following infection with VZV or t 4 HSV is rare, and few necropsy studies of such patients have been published.48 8226 In the main, the patients were severely immunocompromised, although only minor immunosuppression has been noted in other cases. 27 The clinical presentation of fatal HSV and VZV infections is often atypical. The diagnosis remains difficult, particularly in the absence of typical mucocutaneous lesions. In over 80% :
of cases of disseminated HSV infection the diagnosis is only established at necropsy.5 *1 tt. ' Histological examination is frequently r -t^4^$4 needed to confirm the diagnosis. However, the classic features of Herpesviridae infection are it . not always easy to recognise, and may even be absent.9 When Herpesviridae infection is ..^suspected, type-specific identification can be achieved by nucleic acid hybridisation and antigen detection.'01113 The most sensitive method to detect HSV antigens in tissue sections relies on the use ofthe polyclonal antibody to HSVI and HSVII. However, the monoclonal antibodies 1BD4 and HH2 are required for type-specific identification. This study indicates that HSV or VZV antigens and nucleic acids can be present and detectable in some cell types or tissues in the absence of specific Herpesviridae cytopathological changes. This suggests that even when histological examination remains inconclusive, immunohistochemistry and in situ hybridisation can confirm the diagnosis.
In our three patients, intranuclear inclusions were found only in small amounts at the periphery of necrotic areas. In one of the cases reported by Cheatham et 
